Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sanuwave Health Inc (SNWV)

Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 276,582
  • Shares Outstanding, K 8,576
  • Annual Sales, $ 32,630 K
  • Annual Income, $ -31,370 K
  • EBIT $ 8 M
  • EBITDA $ 14 M
  • 60-Month Beta 1.32
  • Price/Sales 8.48
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.17
  • Number of Estimates 2
  • High Estimate 0.21
  • Low Estimate 0.13
  • Prior Year -1.21
  • Growth Rate Est. (year over year) +114.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.45 +13.36%
on 12/09/25
35.29 -8.61%
on 11/26/25
+0.11 (+0.34%)
since 11/19/25
3-Month
25.77 +25.15%
on 11/06/25
40.87 -21.08%
on 10/06/25
-2.63 (-7.54%)
since 09/19/25
52-Week
20.50 +57.32%
on 12/31/24
46.58 -30.77%
on 08/11/25
+10.25 (+46.59%)
since 12/19/24

Most Recent Stories

More News
Sanuwave to Participate in the 44th Annual J.P. Morgan Healthcare Conference

EDEN PRAIRIE, Minn., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-approved next-generation wound care products,...

SNWV : 32.25 (-1.77%)
Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Healogics Wound Care Supply adds UltraMIST to its Group Purchasing Organization Healogics iSupply and Sanuwave collaborate to provide UltraMIST as an option for GPO members EDEN PRAIRIE, Minn.,...

SNWV : 32.25 (-1.77%)
Sanuwave Announces Q3 FY2025 Financial Results

Q3 2025 revenues were  $11.5 million , up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9% , versus...

SNWV : 32.25 (-1.77%)
Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

EDEN PRAIRIE, Minn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will...

SNWV : 32.25 (-1.77%)
CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610)

CMS adopts Final Rule for 2026 Physician Fee Schedule in line with proposed rule for CPT code 97610 2026 rates for physician offices, home visits, long-term care, and hospitals are in line with the...

SNWV : 32.25 (-1.77%)
Roth MKM Reaffirms Their Buy Rating on Sanuwave Health (SNWV)

In a report released yesterday, Kyle Bauser from Roth MKM reiterated a Buy rating on Sanuwave Health, with a price target of $53.00. The company’s shares closed yesterday at $40.82.Elevate Your Investing...

SNWV : 32.25 (-1.77%)
Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)

Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history. Q3 2025...

SNWV : 32.25 (-1.77%)
Sanuwave Health Appoints New Chief Operating Officer

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Sanuwave...

SNWV : 32.25 (-1.77%)
3 Lesser-Known Healthcare Names With Major Upside in Store

These are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity.

BLTE : 156.00 (+0.94%)
SNWV : 32.25 (-1.77%)
AMRX : 12.57 (-0.55%)
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility

Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable Both the term loan and revolver...

SNWV : 32.25 (-1.77%)

Business Summary

SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in...

See More

Key Turning Points

3rd Resistance Point 34.77
2nd Resistance Point 34.16
1st Resistance Point 33.21
Last Price 32.25
1st Support Level 31.65
2nd Support Level 31.04
3rd Support Level 30.09

See More

52-Week High 46.58
Fibonacci 61.8% 36.62
Fibonacci 50% 33.54
Last Price 32.25
Fibonacci 38.2% 30.46
52-Week Low 20.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar